1 / 42

Diabetes and the Eye

Diabetes and the Eye. Presented to DES chapters by the Canadian Association of Optometrists. Diabetes mortality. Three million Canadians will be living with diabetes by the end of this decade. Diabetes contributes to the death of 41,500 Canadians each year.

maitland
Download Presentation

Diabetes and the Eye

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Diabetes and the Eye Presented to DES chapters by theCanadian Association of Optometrists

  2. Diabetes mortality Three million Canadians will be living with diabetes by the end of this decade. Diabetes contributes to the death of 41,500 Canadians each year. Type 2 diabetes shortens life expectancy by 5-10 years.

  3. Diabetes morbidity Diabetes doubles the risk of stroke. Diabetes quadruples the risk of heart disease. Diabetes is the leading cause of non-traumatic lower extremity amputations. Diabetes causes 33% of the new cases of end stage renal disease. Diabetes is the leading cause of blindness in adults aged 25-75.

  4. Components of visual function PSYCHOLOGICAL • visual perception • cognitive functions PHYSICAL PHYSIOLOGICAL • light energy • dioptric system • photoreceptors • neurological processing

  5. Ocular effects of diabetes 8 1. Cornea + tears 2. Aqueous 3. Iris 4. Lens 5. Vitreous 6. Retina 7. Internal muscles 8. External muscles 7 3 6 1 2 4 5 3 7 8

  6. Ocular effects of diabetes Cornea – hypoesthesia, delayed healing, thickness changes Aqueous – glucose concentration, refractive index changes Iris – neovascularization, secondary glaucoma Lens – refractive changes, cataract development Vitreous – lipid deposits, hemorrhage Retina – edema, ischemia, hemorrhage, neovascularization Intraocular muscles – paresis, accommodative dysfunction Extraocular muscles – paresis, sudden onset diplopia

  7. Fluctuating vision Diabetes can cause large shifts in nearsightedness and farsightedness as blood sugar levels fluctuate

  8. Diabetic lens changes Transient hyperopic refractive changes in newly diagnosed juvenile diabetes. Giusti C. Swiss Med Wkly 2003;133:200–205 Transient refractive changes are highly dependent on the magnitude of plasma glucose concentrations Correction of hyperglycemia is strictly correlated with complete recovery of ocular refraction Sorbitol production via the polyol pathway with overhydration of the lens remains the best pathophysiological hypothesis

  9. Cortical cataract

  10. Mature cataract

  11. Cataract surgery – foldable implants

  12. YAG capsulotomy

  13. Diabetic iris changes Ischemia is thought to initiate retinal & iris neovascularization Vascular endothelial growth factor (VEGF) likely plays a central role in neovascularization New vessel growth at the pupillary border, iris surface and iris angle leads to formation of fibrovascular membranes Membranes in the anterior chamber angle block aqueous outflow causing glaucoma

  14. Glaucoma

  15. Canadian Diabetes Association2008 Clinical Practice Guidelines Retinopathy key messages: Screening is important for the detection of treatable disease. Screening intervals for diabetic retinopathy vary according to the individuals age and type of diabetes. Tight glycemic control reduces the onset and progression of sight-threatening diabetic retinopathy. Laser therapy reduces the risk of significant visual loss.

  16. Normal fundus

  17. Retinopathy Individuals with type 1 diabetes 100% will have some diabetic retinopathy after 15-20 years of diagnosis

  18. Retinopathy Individuals with type 2 diabetes 20% will have some diabetic retinopathy at the time of diagnosis 50% will have some diabetic retinopathy after 7 years of diagnosis 85% will have some diabetic retinopathy after 15 years of diagnosis

  19. Dots, blots, microaneurysms

  20. Retinopathy - macular edema Remains the leading cause of vision loss in people living with diabetes Can occur at any time in type 1 and 2

  21. Macular edema

  22. Moderate background diabetic retinopathy

  23. Hypertensive and diabetic retinopathy

  24. Retinopathy NVD

  25. Retinopathy NVE

  26. Canadian Diabetes Association2008 Clinical Practice Guidelines Recommendations: 1. In individuals 15 y/o or older with type 1 diabetes, screening and evaluation for retinopathy by an expert professional should be performed annually starting 5 years after the onset of diabetes 2. In individuals with type 2 diabetes, screening and evaluation by an expert professional should be performed at the time of diagnosis of diabetes. The interval for follow-up assessments should be tailored to the severity of the retinopathy. In those with no or minimal retinopathy, the recommended interval is 1-2 years.

  27. Canadian Diabetes Association2008 Clinical Practice Guidelines 3. Screening for diabetic retinopathy should be performed by experienced professionals, either in person or through interpretation of retinal photographs taken through dilated pupils. 4. To prevent the onset and to delay the progression of diabetic retinopathy, people with diabetes should be treated to achieve optimal control of blood glucose. People with abnormal lipids should be considered at high risk for retinopathy.

  28. Canadian Diabetes Association2008 Clinical Practice Guidelines 5. Patients with sight threatening diabetic retinopathy should be assessed by a general ophthalmologist or retina specialist. Laser therapy and/or vitrectomy and/or pharmacologic intervention should be considered. 6. Visually disabled people should be referred for low vision evaluation and rehabilitation.

  29. Diet

  30. Laser vision correction

  31. Floaters

  32. Basal cell carcinoma

  33. Subconjunctival hemorrhage

  34. Pteyrgium

  35. Retention cyst

  36. Allergic conjunctivitis

  37. Bacterial conjunctivitis

  38. Viral conjunctivitis – pink eye

  39. ARMD

  40. Early dry ARMD

  41. Dry – geographic ARMD

  42. Wet AMD with fibrosis

More Related